Hemorrhagic stroke - pathophysiology

Hemorrhagic stroke involves bleeding into or around the brain, causing tissue damage due to increased pressure, inflammation, and disrupted blood supply. The pathophysiology differs between intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH), with distinct causes and mechanisms of injury. Understanding these differences is critical for effective diagnosis and management.

Hemorrhagic Stroke: Definition and Overview

Hemorrhagic stroke occurs when a blood vessel in the brain ruptures, leading to bleeding within the brain tissue (intracerebral hemorrhage) or into the space surrounding the brain (subarachnoid hemorrhage). Unlike ischemic stroke, which involves a blockage of blood flow, hemorrhagic stroke involves excessive bleeding. This bleeding increases intracranial pressure (ICP), damages brain tissue directly through the pressure exerted by the hematoma, and disrupts the brain's oxygen supply. The pathophysiology revolves around understanding the causes of vessel rupture, the resulting cascade of events, and the mechanisms of brain injury. Hemorrhagic strokes account for approximately 13% of all strokes but are associated with higher morbidity and mortality rates than ischemic strokes. Early recognition and intervention are crucial to improve patient outcomes.

Intracerebral Hemorrhage (ICH): Pathophysiology

Intracerebral hemorrhage (ICH) involves bleeding directly into the brain parenchyma. The most common cause of ICH is hypertension, which weakens arterial walls over time, leading to the formation of microaneurysms (Charcot-Bouchard aneurysms) that can rupture. Other causes include cerebral amyloid angiopathy (CAA), arteriovenous malformations (AVMs), aneurysms, tumors, and coagulopathies. The initial hemorrhage creates a hematoma, which expands and compresses surrounding brain tissue. This mass effect increases ICP and can lead to herniation. Furthermore, the blood itself is toxic to brain tissue. Blood components, such as iron, contribute to oxidative stress and excitotoxicity. The inflammatory response triggered by the hemorrhage further exacerbates brain injury. Management focuses on controlling blood pressure, reversing coagulopathies, and potentially surgically evacuating the hematoma in select cases.

Subarachnoid Hemorrhage (SAH): Pathophysiology

Subarachnoid hemorrhage (SAH) occurs when bleeding occurs into the subarachnoid space, the area between the arachnoid membrane and the pia mater surrounding the brain. The most common cause of SAH is rupture of a cerebral aneurysm, often located at the circle of Willis. Trauma is another significant cause. The sudden release of blood into the subarachnoid space causes a rapid increase in ICP, which can lead to global cerebral ischemia. The presence of blood in the subarachnoid space also triggers a cascade of events, including vasospasm, delayed cerebral ischemia (DCI), and hydrocephalus. Vasospasm, a narrowing of blood vessels, typically occurs 4-14 days after the initial hemorrhage and is a major cause of morbidity and mortality. Hydrocephalus, an accumulation of cerebrospinal fluid (CSF), can result from obstruction of CSF flow by blood clots.

Role of Inflammation in Hemorrhagic Stroke

Inflammation plays a significant role in the secondary brain injury that follows a hemorrhagic stroke. The presence of blood and breakdown products in the brain tissue triggers an inflammatory response, involving activation of microglia, astrocytes, and infiltration of leukocytes. These inflammatory cells release cytokines, chemokines, and other mediators that contribute to neuronal damage. While inflammation is initially intended to clear debris and promote healing, the excessive or prolonged inflammatory response can exacerbate brain injury by increasing edema, disrupting the blood-brain barrier, and promoting excitotoxicity. Therapies aimed at modulating the inflammatory response are being investigated as potential strategies to improve outcomes after hemorrhagic stroke.

Impact of Intracranial Pressure (ICP)

Elevated intracranial pressure (ICP) is a critical consequence of both intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH). The expanding hematoma in ICH and the presence of blood in the subarachnoid space in SAH both increase ICP. Increased ICP reduces cerebral perfusion pressure (CPP), the pressure gradient driving blood flow to the brain. When CPP falls below a critical threshold, cerebral ischemia develops, leading to further brain damage. The Monroe-Kellie doctrine describes the relationship between the components within the skull (brain tissue, blood, and CSF). An increase in one component must be compensated for by a decrease in another to maintain a stable ICP. However, this compensation is limited, and eventually, ICP rises rapidly, leading to herniation, a life-threatening condition where brain tissue is displaced from its normal location. Management of ICP involves measures to reduce brain edema, drain CSF, and in some cases, surgical decompression.

Cerebral Amyloid Angiopathy (CAA) and Hemorrhagic Stroke

Cerebral amyloid angiopathy (CAA) is a condition in which amyloid protein deposits in the walls of small and medium-sized arteries in the brain. This weakens the vessel walls and increases the risk of intracerebral hemorrhage (ICH), particularly in elderly individuals. CAA-related hemorrhages are often lobar in location (i.e., occurring in the lobes of the brain) and may be recurrent. Diagnosis of CAA is often based on clinical and neuroimaging findings, including the presence of multiple microbleeds (small hemorrhages) on MRI. There is no specific treatment for CAA itself, but management focuses on controlling blood pressure and preventing further hemorrhages. Distinguishing CAA-related ICH from hypertensive ICH can be challenging but is important for prognostication and management.

Vasospasm and Delayed Cerebral Ischemia (DCI) in Subarachnoid Hemorrhage

Vasospasm, the narrowing of cerebral arteries, is a major complication of subarachnoid hemorrhage (SAH). It typically occurs 4-14 days after the initial bleed and can lead to delayed cerebral ischemia (DCI), a significant cause of morbidity and mortality. The exact mechanisms underlying vasospasm are not fully understood, but they involve a complex interplay of factors, including release of vasoactive substances from the blood clot, inflammation, and endothelial dysfunction. Diagnosis of vasospasm is usually based on transcranial Doppler (TCD) ultrasound and/or angiography. Treatment strategies include nimodipine (a calcium channel blocker), induced hypertension, and angioplasty to dilate the narrowed vessels.

Common Misconceptions About Hemorrhagic Stroke

Several misconceptions surround hemorrhagic stroke. One common misconception is that all strokes are the same and treated similarly. Hemorrhagic stroke requires a different approach than ischemic stroke, particularly regarding the use of antithrombotic agents. Another misconception is that hemorrhagic stroke is always fatal. While hemorrhagic stroke carries a higher mortality rate than ischemic stroke, many patients survive and can recover with appropriate medical and rehabilitative care. It's also a mistake to assume that only elderly individuals are affected by hemorrhagic stroke. While age is a risk factor, hemorrhagic stroke can occur in younger individuals due to factors such as AVMs, aneurysms, and drug use. Finally, many people underestimate the importance of controlling blood pressure in preventing hemorrhagic stroke. Effective blood pressure management is crucial for reducing the risk of both primary and secondary hemorrhagic strokes.

Browse public study notes